U.S. markets open in 1 hour 52 minutes

Avinger, Inc. (AVGR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.0800+0.0100 (+0.93%)
At close: 4:00PM EDT
1.0900 +0.01 (0.93%)
Pre-Market: 06:58AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Engulfing Line (Bullish)

Engulfing Line (Bullish)

Previous Close1.0700
Open1.0900
Bid0.0000 x 3100
Ask0.0000 x 2200
Day's Range1.0800 - 1.1200
52 Week Range0.2140 - 2.6700
Volume859,308
Avg. Volume2,908,953
Market Cap102.98M
Beta (5Y Monthly)1.60
PE Ratio (TTM)N/A
EPS (TTM)-0.3240
Earnings DateJul 28, 2021 - Aug 02, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Here is What Hedge Funds Think About Avinger Inc (AVGR)
    Insider Monkey

    Here is What Hedge Funds Think About Avinger Inc (AVGR)

    While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors are starting to get cautious towards the current bull run since March, 2020 and hedging or reducing many of their long positions. Some fund managers are betting on Dow […]

  • ACCESSWIRE

    Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference

    REDWOOD CITY, CA / ACCESSWIRE / June 7, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced two podium presentations featuring the company's Lumivascular technology at the New Cardiovascular Horizons (NCVH) annual conference, which took place June 1 through June 4 in New Orleans.

  • ACCESSWIRE

    Avinger Announces Issuance and Allowance of Seven U.S. Patents

    REDWOOD CITY, CA / ACCESSWIRE /May 25, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced the issuance and allowance of seven U.